Dabigatran versus warfarin in patients with atrial fibrillation / Connolly, Sj; Ezekowitz, Md; Yusuf, S; Eikelboom, J; Oldgren, J; Parekh, A; Pogue, J; Reilly, Pa; Themeles, E; Varrone, J; Wang, S; Alings, M; Xavier, D; Zhu, J; Diaz, R; Lewis, Bs; Darius, H; Diener, Hc; Joyner, Cd; Wallentin, L; RE LY Steering, Committee; Investigators, ; Filigheddu, Fabiana. - In: THE NEW ENGLAND JOURNAL OF MEDICINE. - ISSN 0028-4793. - 361:12(2009), pp. 1139-1151. [10.1056/NEJMoa0905561]

Dabigatran versus warfarin in patients with atrial fibrillation

FILIGHEDDU, Fabiana
Membro del Collaboration Group
2009-01-01

2009
Dabigatran versus warfarin in patients with atrial fibrillation / Connolly, Sj; Ezekowitz, Md; Yusuf, S; Eikelboom, J; Oldgren, J; Parekh, A; Pogue, J; Reilly, Pa; Themeles, E; Varrone, J; Wang, S; Alings, M; Xavier, D; Zhu, J; Diaz, R; Lewis, Bs; Darius, H; Diener, Hc; Joyner, Cd; Wallentin, L; RE LY Steering, Committee; Investigators, ; Filigheddu, Fabiana. - In: THE NEW ENGLAND JOURNAL OF MEDICINE. - ISSN 0028-4793. - 361:12(2009), pp. 1139-1151. [10.1056/NEJMoa0905561]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11388/62369
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 9503
  • ???jsp.display-item.citation.isi??? 8240
social impact